Suppr超能文献

人胰腺α-淀粉酶同工型:分离、结构研究及阿卡波糖的抑制动力学

The human pancreatic alpha-amylase isoforms: isolation, structural studies and kinetics of inhibition by acarbose.

作者信息

Ferey-Roux G, Perrier J, Forest E, Marchis-Mouren G, Puigserver A, Santimone M

机构信息

Laboratoire de Biochimie et Biologie de la Nutrition, CNRS-ESA 6033, Faculté des Sciences et Techniques de St. Jérôme, Université d'Aix-Marseille, 13397 Marseille cedex 20, France.

出版信息

Biochim Biophys Acta. 1998 Oct 14;1388(1):10-20. doi: 10.1016/s0167-4838(98)00147-2.

Abstract

A rapid method is proposed for isolating the two main components of human pancreatic alpha-amylase (HPA I and HPA II). The isoelectric point of HPA I (7.2), the main component, was determined using an isoelectrofocusing method and found to differ from that of HPA II (6. 6). The molecular mass of HPA I (55862+/-5 Da) and that of HPA II (55786+/-5 Da) were determined by performing mass spectrometry and found to be quite similar to that of the protein moiety calculated from the amino acid sequence (55788 Da), which indicates that the human amylase is not glycosylated. The structure of both HPA I and HPA II was further investigated by performing limited proteolysis. Two fragments with an apparent molecular mass of 41 kDa and 14 kDa were obtained by digesting the isoforms with proteinase K and subtilisin, whereas digestion with papain yielded two cleaved fragments with molecular masses of 38 kDa and 17 kDa. Proteinase K and subtilisin susceptible bonds are located in the L8 loop (A domain), while the papain cut which occurs in the presence of the calcium chelator EDTA is in the L3 loop (B domain). The kinetics of the inhibition of HPA I and HPA II by acarbose, a drug used to treat diabetes and obesity, were studied using an amylose substrate. The Lineweaver-Burk primary plots of HPA I and HPA II, which did not differ significantly, indicated that the inhibition was of the mixed non-competitive type. The secondary plots gave parabolic curves. All in all, these data provide evidence that two acarbose molecules bind to HPA. In conclusion, apart from the pI, no significant differences were observed between HPA I and HPA II as regards either their molecular mass and limited proteolysis or their kinetic behavior. As was to be expected in view of the high degree of structural identity previously found to exist between human and porcine pancreatic amylases, the present data show that the inhibitory effects of acarbose on the kinetic behavior of these two amylases are quite comparable. In particular, the process of amylose hydrolysis catalyzed by HPA as well as by PPA in both cases requires two carbohydrate binding sites in addition to the catalytic site.

摘要

本文提出了一种快速分离人胰腺α-淀粉酶两种主要成分(HPA I和HPA II)的方法。使用等电聚焦法测定了主要成分HPA I的等电点为7.2,发现其与HPA II的等电点(6.6)不同。通过质谱法测定了HPA I的分子量为55862±5 Da,HPA II的分子量为55786±5 Da,发现它们与根据氨基酸序列计算的蛋白质部分分子量(55788 Da)非常相似,这表明人淀粉酶未被糖基化。通过进行有限的蛋白水解进一步研究了HPA I和HPA II的结构。用蛋白酶K和枯草杆菌蛋白酶消化同工型得到了两个表观分子量分别为41 kDa和14 kDa的片段,而用木瓜蛋白酶消化则产生了两个分子量分别为38 kDa和17 kDa的切割片段。蛋白酶K和枯草杆菌蛋白酶敏感键位于L8环(A结构域),而在钙螯合剂EDTA存在下发生的木瓜蛋白酶切割位于L3环(B结构域)。使用直链淀粉底物研究了用于治疗糖尿病和肥胖症的药物阿卡波糖对HPA I和HPA II的抑制动力学。HPA I和HPA II的Lineweaver-Burk原始图没有显著差异,表明抑制作用为混合非竞争性类型。二级图给出了抛物线曲线。总而言之,这些数据证明两个阿卡波糖分子与HPA结合。总之除了等电点外,在分子量、有限蛋白水解或动力学行为方面,HPA I和HPA II之间未观察到显著差异。鉴于先前发现人和猪胰腺淀粉酶之间存在高度的结构同一性,正如预期的那样本数据表明阿卡波糖对这两种淀粉酶动力学行为的抑制作用相当可比。特别是在这两种情况下,由HPA以及PPA催化的直链淀粉水解过程除了催化位点外还需要两个碳水化合物结合位点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验